Children'S Hospital Corporation

Children'S Hospital Corporation is a research organisation in Boston, United States that has taken part in 11 EU-funded projects since 2012, receiving €1.0M in EU funding.

EU funding received€1.0M
EU projects11
As coordinator0
Running now1
First EU project2012
Latest project2025
CountryUnited States
EU registration (PIC)984564454
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Children'S Hospital Corporation's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€645k · 1 project
  • Horizon 2020€398k · 9 projects
  • Horizon Europe€0 · 1 project

Projects

11 EU-funded projects, newest first. Each links to the official record.

  • GlycoGuardAssociated partner

    Deciphering Glycosphingolipids as Drivers of a Novel Cell-Autonomous Immune Response

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • ReSurfacePartner

    A combined developmental cell biology and tissue engineering approach to repair the articular surface of synovial joints

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

  • GHSOPartner

    Generation of human steroid-producing organoids: a new approach to treat adrenal insufficiency

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

  • HOPEPartner

    automatic detection and localization of High frequency Oscillation in Paediatric Epilepsy

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

  • COAGULANTPartner

    CK2-dependent cytoskeletal regulation and molecular signaling of Neutrophil Extracellular Trap (NET) formation

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

  • BEATPartner

    regulation of B-cell Epitope migration and Autoimmunity by T follicular helper cells

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  • DIRECT TherapiesPartner

    Diabetes Immunoengineering: Redesigning Encapsulated Cell Transplant Therapies

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

  • IMI-PainCarePartner

    Improving the care of patients suffering from acute or chronic pain

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €166ktheir share
  • LeukoTheranosticsPartner

    Harnessing Targeted Nanotheranostics to Reprogram Activated Leukocytes in Inflammatory Bowel Disease

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €176ktheir share
  • MOCHAPartner

    Models of Child Health Appraised

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €57ktheir share
  • PREVENTROPPartner

    New approach to treatment of the blinding disease Retinopathy of Prematurity (ROP)

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €645ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • autoimmune diseases
  • biomaterials
  • carbohydrates
  • cardiovascular diseases
  • cell biology
  • cells technologies
  • diabetes
  • drug discovery
  • economics
  • employment
  • epilepsy
  • genomes
  • governance
  • homeostasis

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime